Importance of method in the determination of syncytium-inducing phenotype of human immunodeficiency virus type 1 clinical isolates

Journal of Virological Methods

Volumn 64, Issue 2, 1997, Pages 137-145

  Liesnard, Corinne ^a   Delforge, Marie Luce ^a   Tchetcheroff, Michel ^a   De Maertelaer, Viviane ^a   Farber, Claire Michèle ^a   Van Vooren, Jean Paul ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

antiretroviral therapy; HIV; non syncytium inducing phenotype; syncytium inducing phenotype

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE SEVERITY; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; SYNCYTIUM;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030933466     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(96)02152-0     Document Type: Article

References (32)

1. Asjo, B., Albert, J., Karlsson, A., Morfeldt-Manson, L., Biberfeld, G., Lidman, K. and Fenyö, E.M. (1986) Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. The Lancet ii, 660-662.
2. Bleul, C.C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, I., Sodroski, J. and Springer, T.A. (1996) The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382, 829-835.
3. + T-Lymphocyte decline and clinical progression in human immunodeficiency virus type-1 infected individuals. J. Virol. 67, 1772-1777.
4. Connor, R.I. and Ho, D.D. (1994) Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J. Virol. 68, 4400-4408.
5. Delforge, M.L., Liesnard, C., Debaisieux, L., Tchetcheroff, M., Farber, C.M. and Van Vooren, J.P. (1995) In vivo inhibition of syncytium-inducing variants of HIV in patients treated with didanosine. AIDS 9, 89-90.
6. Feng, Y., Broder, C.C., Kennedy, P.E. and Berger, E.A. (1996). HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877.
7. Fenyo, E.M., Morfeldt-Manson, L., Chiodi, F., Lind, B., von Gegerfelt, A., Albert, J., Olausson, E. and Asjö, B. (1988) Distinct replicative cytopathic characteristics of human immunodeficiency virus isolates. J. Virol. 62, 4414-4419.
8. Fiore, J.R., Bjorndal, A., Aperia Peipke, K., Di Stefano, M., Angarano, G., Pastore, G., Gaines, H., Fenyö, E.M. and Albert, J. (1994). The biological phenotype of HIV-1 is usually retained during and after sexual transmission. Virology 204, 297-303.
9. Goodenow, M., Huet, T., Saurin, W., Kwok, S., Sninsky, J. and Wain-Hobson, S. (1989) HIV-1 isolates are rapidly evolving quasispecies: Evidence for viral mixtures and preferred nucleotide substitutions. J. AIDS 2, 344-352.
10. Groenink, M., Fouchier, A.M., de Goede, R.E.Y., de Wolf, F., Gruters, R.A., Cuypers, T.M., Huisman, H.G. and Tersmette, M. (1991) Phenotypic heterogeneity in a panel of infectious molecular human immunodeficiency virus type 1 clones derived from a single individual. J. Virol. 65, 1968-1975.
11. Hogervorst, E., Jurriaans, S., de Wolf, F., van Wijk, A., Wiersma, A., Valk, M., Roos, M., van Gemen, B., Coutinho, R., Miedema, F. and Goudsmit, J. (1995) Predictors for non-and slow progression in human immunodeficiency virus (HIV) type 1 infection: low virus RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels. J. Infect. Dis. 171, 811-821.
12. Hollinger, F.B., Bremer, J.W., Myers, L.E., Gold, J.W.M., McQuay, L. and The NIH/NIAID/DAIDS/ACTG virology laboratories (1992) Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS clinical trials group. J. Clin. Microbiol. 30, 1787-1794.
13. Innocenti-Francillard, P., Brengel, K., Guillon, C., Mallet, F., Morand, P., Gruters, R. and Seigneurin, J.M. (1994) Blood monocytes infected In Vivo by HIV-1 variants with a syncytium-inducing phenotype. AIDS Res. Hum. Retroviruses 10, 683-690.
14. Japour, A.J., Fiscus, S.A., Arduino, J.M., Mayers, D.L., Reichelderfer, P.S. and Kuritzkes, D.R. (1994) Standardized microtiter assay for determination of syncytium-inducing phenotypes of clinical human immunodeficiency virus type 1 isolates. J. Clin. Microbiol. 32, 2291-2294.
15. Karlsson, A., Parsmyr, K., Sandstrom, E., Fenyö, E.M. and Albert, J. (1994) MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection. J. Clin. Microbiol. 32, 364-370.
16. Koot, M., Vos, A.H.V., Keet, R.P.M., de Goede, R.E.Y., Wouters Dercksen, M., Terpstra, F.G., Coutinho, R.A., Miedema, F. and Tersmette, M. (1992) HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS 6, 49-5.
17. + cell depletion and progression to AIDS. Ann. Intern. Med. 118, 681-688.
18. Koot, M., Schellekens, P.T.A., Mulder, J.W., Lange, J.M.A., Roos, M.T.L., Coutinho, R.A., Tersmette, M. and Miedema, F. (1993b) Viral phenotype and T-cell reactivity in human immunodeficiency virus type-1 infected asymptomatic men treated with Zidovudine. J. Infect. Dis. 168, 733-736.
19. Koot, M., van't Wout, A.B., Kootstra, N.A., de Goede, R.E.Y., Tersmette, M. and Schuitemaker, H. (1996) Relation between changes in cellular load, evolution of viral phenotype, and the clonal composition of virus populations in the course of human immunodeficiency virus type 1 infection. J. Infect. Dis. 173, 349-354.
20. Kusumi, K., Conway, B., Cunningham, S., Berson, A., Evans, C., Iversen, A.K.N., Colvin, D., Gallo, M.V., Coutre, S., Shpaer, E.G., Faulkner, D.V., deRonde, A., Volkman, S., Williams, C., Hirsch, M.S. and Mullins, J.I. (1992) Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro. J. Virol. 66, 875-885.
21. Nielsen, C., Pedersen, C., Lundgren, J.D. and Gerstoft, J. (1993) Biological properties of HIV isolates in primary HIV infection: consequences for the subsequent course of infection. AIDS 7, 1035-1040.
22. Nkengasong, J.N., Peeters, M., Nys, P., Willems, B., Piot, P. and van der Groen, G. (1995) Infectious virus titer, replicative and syncytium-inducing capacity of human immunodeficiency virus type 1. J. Med. Virol. 45, 78-81.
23. Richman, D.D. and Bozzette, S.A. (1994) The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J. Infect. Dis. 169, 968-974.
24. Schuitemaker, H., Kootstra, N.A., de Goede, R.E.Y., de Wolf, F., Miedema, F. and Tersmette, M. (1991) Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture. J. Virol. 65, 356-363.
25. Schuitemaker, H., Koot, M., Kootstra, N.A., Wouter Dercksen, M., de Goede, R.E.Y., van Steenwijk, R.P., Lange, J.M.A., Eeftink Schattenkerk, J.L.M., Miedema, F. and Tersmette, M. (1992) Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J. Virol. 66, 1354-1360.
26. Shafer, R.W., Aguiniga, E. and Merigan, T.C. (1995) Quantitative analysis of syncytium-inducing and non-syncytium-inducing virus in patients infected with human immunodeficiency virus type 1. J. Clin. Microbiol. 33, 212-214.
27. St Clair, M.H., Hartigan, P.M., Andrews, J.C., Vavro, C.L., Simberkoff, M.S., Hamilton, J.D. and the VA Cooperative Study Group (1993) Zidovudine resistance, syncytium-inducing phenotype, and HIV disease progression in a case-control study. J. AIDS 6, 891-897.
28. Tersmette, M., de Goede, R.E.Y., Al, B.J.M., Winkel, I.N., Gruters, R.A., Cuypers, H.T., Huisman, H.G. and Miedema, F. (1988) Differential syncitium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J. Virol. 62, 2026-2032.
29. Tersmette, M., Gruters, R.A., de Wolf, F., de Goede, R.E.Y., Lange, J.M.A., Schellekens, P.T.A., Goudsmit, J., Huisman, H.G. and Miedema, F. (1989a) Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J. Virol. 63, 2118-2125.
30. Tersmette, M., de Goede, R.E.Y., Eftink-Schattenkerk, J.K.M., Schellekens, P.T.A., Coutinho, R.A., Goudsmit, J., Lange, J.M.A., De Wolf, F., Huisman, J.G. and Miedema, F. (1989b). Association between biological properties of human immunodefiency virus variants and risk for AIDS and AIDS mortality. The Lancet i, 983-985.
31. + T-cell lines from normal donors by human immunodeficiency virus type 1 isolates with non-syncytium-inducing genotype and phenotype in MT-2 cells. J. Virol. 69, 7099-7105.
32. Zheng, N.N., McQueen, P.W., Hurren, L., Evans, L.A., Law, M.G., Forde, S., Barker, S., Cooper, D.A. and Delaney, S.F. (1996) Changes in biologic phenotype of human immunodeficiency virus during treatment of patients with didanosine. J. Infect. Dis. 173, 1092-1096.